HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurie Markman Selected Research

Carboplatin (JM8)

11/2020Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery.
3/2014Advances in cervical cancer pharmacotherapies.
9/2011Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer.
4/2011Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
1/2011Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer.
8/2010Early onset of platinum hypersensitivity in a dentist: a case report.
3/2010Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.
12/2009"Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma" Safra T, et al (Gynecol Oncol 2009; 114:215-218).
10/2009Ovarian cancer.
9/2009Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurie Markman Research Topics

Disease

121Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2002
101Neoplasms (Cancer)
04/2019 - 02/2002
31Ovarian Epithelial Carcinoma
11/2020 - 02/2002
25Carcinoma (Carcinomatosis)
01/2019 - 02/2002
15Disease Progression
01/2014 - 05/2002
12Hypersensitivity (Allergy)
08/2010 - 02/2002
11Breast Neoplasms (Breast Cancer)
11/2018 - 08/2006
10Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2014 - 04/2002
9Endometrial Neoplasms (Endometrial Cancer)
04/2019 - 06/2003
7Adenocarcinoma
12/2014 - 04/2003
7Neutropenia
01/2007 - 03/2003
7Peripheral Nervous System Diseases (PNS Diseases)
08/2006 - 05/2002
5Lung Neoplasms (Lung Cancer)
09/2017 - 06/2002
5Fallopian Tube Neoplasms
08/2004 - 05/2002
4Thrombocytopenia (Thrombopenia)
05/2015 - 12/2004
4Colorectal Neoplasms (Colorectal Cancer)
12/2014 - 04/2004
4Vomiting
04/2003 - 06/2002
3Anemia
05/2015 - 10/2004
3Peritoneal Neoplasms
12/2014 - 04/2004
3Pleural Effusion (Pleural Effusions)
03/2009 - 03/2003
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2008 - 06/2002
3Fatigue
09/2005 - 04/2003
3Ascites
10/2003 - 03/2003
3Nausea
04/2003 - 06/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 01/2005
2Brain Neoplasms (Brain Tumor)
12/2014 - 01/2013
2Neoplasm Metastasis (Metastasis)
12/2014 - 01/2014
2Brain Diseases (Brain Disorder)
05/2014 - 01/2014
2Lymphoma (Lymphomas)
03/2011 - 06/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2010 - 04/2002
2Chronic Disease (Chronic Diseases)
12/2009 - 07/2004
2Pain (Aches)
09/2009 - 08/2004
2Kidney Neoplasms (Kidney Cancer)
01/2008 - 01/2007
2Leukemia
11/2007 - 07/2004
2Carcinosarcoma
02/2007 - 11/2004
2Fever (Fevers)
08/2006 - 02/2004
2Anaphylaxis (Anaphylactic Shock)
01/2004 - 12/2003
2Edema (Dropsy)
11/2003 - 03/2003
2Arthralgia (Joint Pain)
11/2003 - 03/2003
1Adenocarcinoma of Lung
09/2017

Drug/Important Bio-Agent (IBA)

61Paclitaxel (Taxol)FDA LinkGeneric
11/2020 - 02/2002
59PlatinumIBA
07/2019 - 02/2002
44Carboplatin (JM8)FDA LinkGeneric
11/2020 - 02/2002
29Pharmaceutical PreparationsIBA
07/2019 - 07/2002
24Cisplatin (Platino)FDA LinkGeneric
03/2014 - 04/2002
17liposomal doxorubicin (Doxil)FDA Link
01/2014 - 11/2003
15taxaneIBA
07/2019 - 05/2003
13Antineoplastic Agents (Antineoplastics)IBA
10/2014 - 05/2003
13Docetaxel (Taxotere)FDA Link
06/2014 - 03/2003
9Biological ProductsIBA
01/2018 - 12/2003
8GemcitabineFDA Link
01/2013 - 02/2002
8CA-125 Antigen (CA 125 Antigen)IBA
03/2011 - 07/2003
7Topotecan (Hycamtin)FDA LinkGeneric
03/2014 - 06/2004
71-dodecylpyridoxal (PLD)IBA
01/2014 - 07/2004
5Bevacizumab (Avastin)FDA Link
03/2014 - 02/2007
4Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2019 - 08/2010
4Biomarkers (Surrogate Marker)IBA
04/2019 - 04/2009
4Tumor Biomarkers (Tumor Markers)IBA
01/2013 - 10/2006
4Taxoids (Taxanes)IBA
02/2008 - 03/2003
4Irinotecan (Camptosar)FDA LinkGeneric
02/2007 - 05/2003
3Etoposide (VP 16)FDA LinkGeneric
02/2007 - 07/2004
3ErythropoietinFDA Link
01/2006 - 09/2002
2ErbB Receptors (EGF Receptor)IBA
09/2016 - 01/2013
2Proteins (Proteins, Gene)FDA Link
09/2015 - 11/2011
2Hemoglobins (Hemoglobin)IBA
05/2015 - 10/2004
2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2014 - 01/2013
2Capecitabine (Xeloda)FDA Link
12/2014 - 01/2013
2Lapatinib (GW572016)FDA Link
12/2014 - 01/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2014 - 10/2006
2DNA (Deoxyribonucleic Acid)IBA
04/2011 - 08/2010
2Cytotoxins (Cytolysins)IBA
01/2011 - 01/2005
2AntigensIBA
04/2009 - 11/2007
2IfosfamideFDA LinkGeneric
02/2007 - 04/2002
2Vinorelbine (Navelbine)FDA LinkGeneric
02/2007 - 12/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2006 - 03/2003
2Progesterone Receptors (Progesterone Receptor)IBA
03/2005 - 06/2003
2AnthracyclinesIBA
12/2004 - 03/2003
2TamoxifenFDA LinkGeneric
08/2004 - 05/2004
2Drug CombinationsIBA
01/2004 - 05/2003
1Platinum Compounds (Compounds, Platinum)IBA
01/2019
1human ERBB2 proteinIBA
11/2018
1Sirolimus (Rapamycin)FDA Link
01/2018
1temsirolimusFDA Link
01/2018
1Immune Checkpoint InhibitorsIBA
01/2018

Therapy/Procedure

94Drug Therapy (Chemotherapy)
01/2022 - 02/2002
78Therapeutics
04/2019 - 02/2002
7Hyperthermic Intraperitoneal Chemotherapy
01/2016 - 04/2004
7Neoadjuvant Therapy
04/2010 - 01/2005
6Cytoreduction Surgical Procedures
11/2020 - 01/2005
6Maintenance Chemotherapy
03/2015 - 11/2003
5Radiotherapy
01/2008 - 11/2003
4Complementary Therapies (Alternative Medicine)
01/2016 - 09/2002
4Drug Tapering
08/2006 - 06/2002
2Precision Medicine
12/2012 - 01/2007
2Induction Chemotherapy
05/2011 - 01/2010
2Retreatment
02/2009 - 05/2002
2Duration of Therapy
02/2008 - 01/2005
2Salvage Therapy
02/2006 - 12/2004
2Combination Drug Therapy (Combination Chemotherapy)
01/2004 - 10/2003
1Immunotherapy
04/2019